Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
AnnJi Pharmaceutical Announced a Licensing Agreement With Avenue Therapeutics For The Treatment Of Kennedy's Disease
AnnJi Pharmaceutical has entered into an exclusive license agreement with Avenue Therapeutics for the development and […]
Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Support Next Phase of Growth
Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in lentiviral […]
CNS Pharmaceuticals Continues Momentum in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM with First Patient Enrolled in Switzerland
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Aldevron and Evanoa Sign Licensing Agreement
Evanoa Bioscience, a cell line developer for biologics manufacturing, together with Aldevron, a global leader […]
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
QIAGEN today announced it has entered into a strategic partnership with Servier, a global pharmaceutical […]
Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU
Telix Pharmaceuticals today announces presentations from the Company’s carbonic anhydrase IX (CAIX) targeting kidney and […]
JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma
JW Therapeutics, an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell […]
MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules
MIMETAS, a leading company in the field of organ-on-a-chip-based disease models, announces that it has […]
Restore Medical Announces Successful First-In-Human Preliminary Results of Its CONTRABAND™ System for Symptomatic Systolic Heart Failure Patients
Restore Medical, a privately held medical device company, has successfully completed enrollment of the First […]
Virion Therapeutics Presents Promising Preclinical Cancer Data When Using a Novel Genetically Encoded Checkpoint Modifier-Based Immunotherapy
Virion Therapeutics, a clinical-stage biotech company focused on the development of novel, adaptable, and accessible CD8+ T […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more